beta Amyloid antibody (AA 500-700)
Quick Overview for beta Amyloid antibody (AA 500-700) (ABIN7875428)
Target
See all beta Amyloid (Abeta) AntibodiesReactivity
Host
Clonality
Conjugate
Application
Grade
Clone
-
-
Binding Specificity
- AA 500-700
-
Purpose
- Amyloid beta Antibody / APP (azide and preservative free)
-
Purification
- Protein A/G affinity
-
Immunogen
- A recombinant fragment (within amino acids 500-700) of human APP protein was used as the immunogen for the Amyloid beta antibody.
-
Isotype
- IgG2b, kappa
-
-
-
-
Application Notes
- Optimal dilution of the Amyloid beta antibody should be determined by the researcher.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 1 mg/mL
-
Buffer
- 1 mg/mL in 1X PBS, BSA free, sodium azide free
-
Preservative
- Azide free
-
Storage
- -20 °C
-
Storage Comment
- Aliquot the Amyloid beta antibody and store frozen at -20oC or colder. Avoid repeated freeze-thaw cycles.
-
-
- beta Amyloid (Abeta) (Amyloid beta (Abeta))
-
Alternative Name
- Amyloid beta
-
Background
- Proteolytic cleavage of the Amyloid protein precursor (APP) gives rise to the b-Amyloid and Amyloid A4 proteins, which are present in human platelets. Amyloid deposition is associated with type II diabetes, Down syndrome and a variety of neurological disorders, including Alzheimer s disease. The Amyloid precursor protein (APP) undergoes alternative splicing, resulting in several isoforms. Proteolytic cleavage of APP leads to the formation of the Amyloid b/A4 Amyloid protein. This protein is involved in the formation of neurofibrillary tangles and plaques that characterize the senile plaques of Alzheimer s patients. APLP1 (Amyloid precursor-like protein 1) and APLP2 are structurally similar to APP. Human APLP2 is a membrane-bound sperm protein that contains a region highly homologous to the transmembrane-cytoplasmic domains of APP found in brain plaques of Alzheimer s disease patients.
-
UniProt
- P05067
-
Pathways
- Inflammasome
Target
-